Company News
Circularity Healthcare Negotiating $100 million Institutional Funding, Expands Successful D’OXYVA Pivotal Diabetic Foot Ulcer Treatment Clinical Trials, Expects Fast-Track FDA Approval
[Los Angeles, CA, July 16, 2019] Circularity Healthcare LLC, developer and manufacturer of transdermal drug delivery and wound healing products, has announced that the company